{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T17:29:30Z","timestamp":1767374970731,"version":"3.37.3"},"reference-count":83,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T00:00:00Z","timestamp":1577404800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0227133","type":"journal-article","created":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T13:28:01Z","timestamp":1577453281000},"page":"e0227133","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Comprehensive assessment of tissue and serum parameters of bone metabolism in a series of orthopaedic patients"],"prefix":"10.1371","volume":"14","author":[{"given":"Jan","family":"Gunsser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regina","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Roth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0141-7310","authenticated-orcid":true,"given":"Amelie","family":"Lupp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,12,27]]},"reference":[{"volume-title":"Bone Health and Osteoporosis: A Report of the Surgeon General","year":"2004","author":"U.S. Department of Health and Human Services","key":"pone.0227133.ref001"},{"key":"pone.0227133.ref002","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ecl.2015.05.002","article-title":"Bone Health and osteoporosis","volume":"44","author":"BC Lupsa","year":"2015","journal-title":"Endocinol Metab Clin N Am"},{"key":"pone.0227133.ref003","doi-asserted-by":"crossref","first-page":"171","DOI":"10.5312\/wjo.v7.i3.171","article-title":"Major osteoporotic fragility fractures: risk factor updates and social impact","volume":"7","author":"P Pisani","year":"2016","journal-title":"World J Orthop"},{"key":"pone.0227133.ref004","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1210\/endo.142.12.8536","article-title":"Minireview: the OPG\/RANKL\/RANK system","volume":"142","author":"S Khosla","year":"2001","journal-title":"Endocrinol"},{"key":"pone.0227133.ref005","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1210\/endo.142.9.8356","article-title":"Catabolic effects of continuous human PTH (1\u201338) in vivo is associated with sustained stimulation of RANKL and inhibition of OPG and gene-associated bone formation","volume":"142","author":"YL Ma","year":"2001","journal-title":"Endocrinology"},{"key":"pone.0227133.ref006","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2174\/1381612013397807","article-title":"Osteoprotegerin: a physiological and pharmacological inhibitor of bone resorption","volume":"7","author":"PJ Kostenuik","year":"2001","journal-title":"Curr Pharm Des"},{"key":"pone.0227133.ref007","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1359\/JBMR.0301226","article-title":"PTH differentially regulates expression of RANKL and OPG","volume":"19","author":"JC Huang","year":"2004","journal-title":"J Bone Miner Res"},{"key":"pone.0227133.ref008","doi-asserted-by":"crossref","first-page":"89958","DOI":"10.18632\/oncotarget.21194","article-title":"Evaluation of somatostatin, CXCR4 chemokine and endothelin A receptor expression in a large set of paragangliomas","volume":"8","author":"D Kaemmerer","year":"2017","journal-title":"Oncotarget"},{"key":"pone.0227133.ref009","first-page":"979","article-title":"Immunohistochemical identification of the PTHR1 in normal and neoplastic human tissues","volume":"162","author":"A Lupp","year":"2010","journal-title":"Mol Endocrinol"},{"key":"pone.0227133.ref010","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0221-8747(79)90024-9","article-title":"Histomorphometric profile, pathophysiology and reversibility of cortico-steroid-induced osteoporosis","volume":"1","author":"C Bressot","year":"1979","journal-title":"Metab Bone Dis Rel Res"},{"key":"pone.0227133.ref011","first-page":"138","article-title":"Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue","volume":"8","author":"W Remmele","year":"1987","journal-title":"Pathologe"},{"key":"pone.0227133.ref012","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00223-013-9774-y","article-title":"Osteocyte-driven bone remodeling","volume":"94","author":"T Bellido","year":"2014","journal-title":"Calcif Tissue Int"},{"key":"pone.0227133.ref013","doi-asserted-by":"crossref","first-page":"e000049","DOI":"10.1136\/rmdopen-2015-000049","article-title":"The osteocyte: key player in regulating bone turnover","volume":"1","author":"SR Goldring","year":"2014","journal-title":"RMD Open"},{"key":"pone.0227133.ref014","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00223-013-9790-y","article-title":"Osteocytes: master orchestrators of bone","volume":"94","author":"MB Schaffler","year":"2014","journal-title":"Calcif Tissue Int"},{"key":"pone.0227133.ref015","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1210\/endo-113-2-805","article-title":"Immunohistochemical demonstration of parathyroid hormone binding to specific cell types in fixed rat bone tissue","volume":"113","author":"LG Rao","year":"1983","journal-title":"Endocrinology"},{"key":"pone.0227133.ref016","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1210\/endo-123-1-187","article-title":"In vivo distribution of parathyroid hormone receptors in bone: evidence that a predominant osseous target cell is not the mature osteoblast","volume":"123","author":"MF Rouleau","year":"1988","journal-title":"Endocrinol"},{"key":"pone.0227133.ref017","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1210\/endo.134.1.8275957","article-title":"Parathyroid hormone induces sequential c-fos expression in bone cells in vivo: in situ localisation of its receptor and c-fos messenger ribonucleic acids","volume":"134","author":"K Lee","year":"1994","journal-title":"Endocrinol"},{"key":"pone.0227133.ref018","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1002\/jbmr.5650101213","article-title":"PTH\/PTHrP receptor expression on osteoblasts and osteocytes but not resorbing bone surfaces in growing rats","volume":"10","author":"B Fermor","year":"1995","journal-title":"J Bone Miner Res"},{"key":"pone.0227133.ref019","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1046\/j.1523-1755.2000.00306.x","article-title":"Down-regulation of human osteoblast PTH\/PTHrP receptor mRNA in end-stage renal failure","volume":"58","author":"ML Picton","year":"2000","journal-title":"Kidney Int"},{"key":"pone.0227133.ref020","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1359\/jbmr.2001.16.8.1416","article-title":"Expression profiles of receptor activator of nuclear factor \u03baB ligand, receptor activator of nuclear factor \u03baB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones","volume":"16","author":"T Ikeda","year":"2001","journal-title":"J Bone Miner Res"},{"key":"pone.0227133.ref021","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1359\/jbmr.2001.16.3.448","article-title":"Parathyroid hormone\/parathyroid hormone-related peptide type 1 receptor in human bone","volume":"16","author":"MC Langub","year":"2001","journal-title":"J Bone Miner Res"},{"key":"pone.0227133.ref022","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10735-004-3839-1","article-title":"Detection of osteoprotegerin (OPG) and its ligand (RANKL) mRNA and protein in femur and tibia of the rat","volume":"36","author":"G Silvestrini","year":"2004","journal-title":"J Mol Hist"},{"key":"pone.0227133.ref023","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.tice.2005.03.002","article-title":"Osteoprotegerin (OPG) and RANKL expression and distribution in developing human craniomandibular joint","volume":"37","author":"C Carda","year":"2005","journal-title":"Tissue & Cell"},{"key":"pone.0227133.ref024","doi-asserted-by":"crossref","first-page":"e2942","DOI":"10.1371\/journal.pone.0002942","article-title":"Control of bone mass and remodeling by PTH receptor signaling in osteocytes","volume":"3","author":"CA O\u00b4Brien","year":"2008","journal-title":"PLoS One"},{"key":"pone.0227133.ref025","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/jbmr.304","article-title":"PTH receptor signaling in osteocytes governs periosteal bone formation and intracortical remodeling","volume":"26","author":"Y Rhee","year":"2011","journal-title":"J Bone Miner Res"},{"key":"pone.0227133.ref026","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1530\/JOE-10-0308","article-title":"Targeted ablation of the PTH\/PTHrP receptor in osteocytes impairs bone structure and homeostatic calcemic responses","volume":"209","author":"WF Powell","year":"2011","journal-title":"J Endocrinol"},{"key":"pone.0227133.ref027","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1002\/jbmr.1941","article-title":"RANKL subcellular trafficking and regulatory mechanisms in osteocytes","volume":"28","author":"M Honma","year":"2013","journal-title":"J Bone Miner Res"},{"key":"pone.0227133.ref028","doi-asserted-by":"crossref","first-page":"20122","DOI":"10.1074\/jbc.M112.441360","article-title":"Parathyroid hormone (PTH)\/PTH-related peptide type 1 receptor (PPR) signaling in osteocytes regulates anabolic and catabolic skeletal responses to PTH","volume":"288","author":"V Saini","year":"2013","journal-title":"J Biol Chem"},{"key":"pone.0227133.ref029","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S8756-3282(99)00214-8","article-title":"Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues","volume":"25","author":"V Kartsogiannis","year":"1999","journal-title":"Bone"},{"key":"pone.0227133.ref030","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/ar.1127","article-title":"Immunolocalization of vacuolar-type H+-ATPase, cathepsin K, matrix metalloproteinase-9, and receptor activator of NFkappaB ligand in odontoclasts during physiological root resorption of human deciduous teeth","volume":"264","author":"T Oshiro","year":"2001","journal-title":"Anat Rec"},{"key":"pone.0227133.ref031","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/jcb.20388","article-title":"Normal human osteoclasts formed from peripheral blood monocytes express PTH type 1 receptors and are stimulated by PTH in the absence of osteoblasts","volume":"95","author":"DW Dempster","year":"2005","journal-title":"J Cell Biochem"},{"key":"pone.0227133.ref032","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1083\/jcb.94.2.379","article-title":"Parathyroid hormone receptor in intact embryonic chicken bone: characterization and cellular localization","volume":"94","author":"CM Silve","year":"1982","journal-title":"J Cell Biol"},{"key":"pone.0227133.ref033","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1177\/002215540205000708","article-title":"Localization of osteoprotegerin (OPG) on bone surfaces and cement lines in rat tibia","volume":"50","author":"H Nakamura","year":"2002","journal-title":"J Histochem Cytochem"},{"key":"pone.0227133.ref034","first-page":"157","article-title":"Changes in trabecular bone, hematopoieses and bone marrow vessels in aplastic anemia, primary osteoporosis, and old age: a comparative histomorphometric study","volume":"8","author":"R Burkhardt","year":"1987","journal-title":"Pergamon J"},{"key":"pone.0227133.ref035","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/S0140-6736(02)08706-8","article-title":"Pathogenesis of bone fragility in women and men","volume":"359","author":"E Seeman","year":"2002","journal-title":"Lancet"},{"key":"pone.0227133.ref036","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1152\/japplphysiol.00564.2003","article-title":"Invited Review: Pathogenesis of osteoporosis","volume":"95","author":"E Seeman","year":"2003","journal-title":"J Appl Physiol"},{"key":"pone.0227133.ref037","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1101\/gad.12.9.1260","article-title":"Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification","volume":"12","author":"N Bucay","year":"1998","journal-title":"Genes Dev"},{"key":"pone.0227133.ref038","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1093\/ndt\/gfn302","article-title":"\u00b4Riordan SE, Eaglestone GL, Delaney MP, Lamb EJ. Bone mineral metabolism and its relationship to kidney disease in a residential care home population: a cross-sectional study","volume":"23","author":"O Carter JL","year":"2008","journal-title":"Nephro Dial Transplant"},{"key":"pone.0227133.ref039","doi-asserted-by":"crossref","first-page":"R2","DOI":"10.1186\/ar2348","article-title":"Circulating RANKL is inversely correlated to RANKL mRNA levels in bone in osteoarthritic males","volume":"10","author":"D Findlay","year":"2008","journal-title":"Arth Res Ther"},{"key":"pone.0227133.ref040","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1210\/jc.2007-2492","article-title":"Increased plasma osteoprotegerin concentrations are associated with indices of bone strength of the hip","volume":"93","author":"EJ Samelson","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"pone.0227133.ref041","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF03345584","article-title":"Circulating profiles of osteoprotegerin and soluble receptor activator of nuclear factor kappaB ligand in post-menopausal women","volume":"31","author":"H Uemura","year":"2008","journal-title":"J Endocrinol Invest"},{"key":"pone.0227133.ref042","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00198-007-0440-y","article-title":"Relationships between insulin-like growth factor-I (IGF-I) and OPG, RANKL, bone mineral density in healthy Chinese women","volume":"19","author":"HY Zhao","year":"2008","journal-title":"Osteoporos Int"},{"key":"pone.0227133.ref043","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1097\/gme.0b013e3181a181b8","article-title":"Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory","volume":"16","author":"I Nabipour","year":"2009","journal-title":"Menopause"},{"key":"pone.0227133.ref044","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2013.05.018","article-title":"OPG and sRANKL serum levels and incident hip fracture in postmenopausal Caucasian women in the Women's Health Initiative Observational Study","volume":"56","author":"AZ LaCroix","year":"2013","journal-title":"Bone"},{"key":"pone.0227133.ref045","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.maturitas.2013.01.005","article-title":"Multiparameter analysis of serum levels of C-telopeptide crosslaps, bone-specific alkaline phosphatase, cathepsin K, osteoprotegerin and receptor activator of nuclear factor \u03baB ligand in the diagnosis of osteoporosis","volume":"74","author":"S Piatek","year":"2013","journal-title":"Maturitas"},{"key":"pone.0227133.ref046","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00774-013-0532-z","article-title":"Parathyroid-hormone variance is only marginally explained by a panel of determinants: a cross-sectional study of 909 hip-fracture patients","volume":"32","author":"M Di Monaco","year":"2014","journal-title":"J Bone Miner Metab"},{"key":"pone.0227133.ref047","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1359\/jbmr.1999.14.4.518","article-title":"Immunological characterization of circulating osteoprotegerin\/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis","volume":"14","author":"K Yano","year":"1999","journal-title":"J Bone Miner Res"},{"key":"pone.0227133.ref048","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF03040334","article-title":"Osteoprotegerin serum levels in women: correlation with age, bone mass, bone turnover and fracture status","volume":"115","author":"A Fahrleitner-Pammer","year":"2003","journal-title":"Wien Klin Wochenschr"},{"key":"pone.0227133.ref049","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00223-004-0007-2","article-title":"Relationships between the changes of serum levels of OPG and RANKL with age, menopause, bone biochemical markers and bone mineral density in Chinese women aged 20\u201375","volume":"76","author":"JM Liu","year":"2005","journal-title":"Calcif Tissue Int"},{"key":"pone.0227133.ref050","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1161\/01.RES.0000149165.99974.12","article-title":"Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin","volume":"95","author":"P Collin-Osdoby","year":"2004","journal-title":"Circ Res"},{"key":"pone.0227133.ref051","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1161\/01.CIR.0000127957.43874.BB","article-title":"Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease","volume":"109","author":"S Kiechl","year":"2004","journal-title":"Circulation"},{"key":"pone.0227133.ref052","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.atherosclerosis.2008.09.033","article-title":"Osteoprotegerin, vascular calcification and atherosclerosis","volume":"204","author":"A Van Campenhout","year":"2009","journal-title":"Atherosclerosis"},{"key":"pone.0227133.ref053","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/j.jacc.2010.03.013","article-title":"Osteoprotegerin as a predictor of coronary artery disease and cardiovascular mortality and morbidity","volume":"55","author":"SM Venuraju","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"pone.0227133.ref054","first-page":"182060","article-title":"Osteoprotegerin as a marker of atherosclerosis in diabetic patients","author":"A Augoulea","year":"2013","journal-title":"Int J Endocrinol"},{"key":"pone.0227133.ref055","article-title":"Osteoprotegerin concentration and risk of cardiovascular outcomes in nine general population studies: Literature-based meta-analysis involving 26,442 participants","author":"L Tschiederer","year":"2017","journal-title":"PLOS ONE"},{"key":"pone.0227133.ref056","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3390\/ijms20030705","article-title":"The role of osteoprotegerin and its ligands in vascular function","volume":"20","author":"L Rochette","year":"2019","journal-title":"Int J Mol Sci"},{"key":"pone.0227133.ref057","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1002\/jbmr.479","article-title":"Determinants of serum sclerostin in healthy pre- and postmenopausal women","volume":"26","author":"MS Ardawi","year":"2011","journal-title":"J Bone Miner Res"},{"key":"pone.0227133.ref058","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/jbmr.217","article-title":"Relation of age, gender, and bone mass to circulating sclerostin levels in women and men","volume":"26","author":"UI M\u00f6dder","year":"2011","journal-title":"J Bone Miner Res"},{"key":"pone.0227133.ref059","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2013.10.019","article-title":"Effects of age on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in humans","volume":"59","author":"MM Roforth","year":"2013","journal-title":"Bone"},{"key":"pone.0227133.ref060","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1001\/jama.291.9.1108","article-title":"Soluble RANKL and risk of nontraumatic fracture","volume":"291","author":"G Schett","year":"2004","journal-title":"JAMA"},{"key":"pone.0227133.ref061","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1007\/BF03350814","article-title":"sRANKL\/osteoprotegerin complex and biochemical markers in a cohort of male and female hemodialysis patients","volume":"30","author":"KK Doumouchtsis","year":"2007","journal-title":"J Endocrinol Invest"},{"key":"pone.0227133.ref062","first-page":"382","article-title":"Age and gender predict OPG level and OPG\/sRANKL ratio in maintenance hemodialysis patients","volume":"58","author":"B Naumnik","year":"2013","journal-title":"Adv Mol Sci"},{"issue":"Suppl 1","key":"pone.0227133.ref063","first-page":"T411","article-title":"Osteoprotegerin levels in healthy volunteers","volume":"23","author":"HM Arrighi","year":"1998","journal-title":"Bone"},{"key":"pone.0227133.ref064","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s001980200045","article-title":"Correlates of osteoprotegerin levels in women and men","volume":"13","author":"S Khosla","year":"2002","journal-title":"Osteoporos Int"},{"key":"pone.0227133.ref065","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/01.MIB.0000164015.60795.ca","article-title":"Serum osteoprotegerin is increased in Crohn\u2019s disease: a population-based case control study","volume":"11","author":"CN Bernstein","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"pone.0227133.ref066","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00198-009-1035-6","article-title":"Bone loss in relation to serum levels of osteoprotegerin and nuclear factor-\u03baB ligand: The Troms\u00f8 Study","volume":"21","author":"L J\u00f8rgensen","year":"2010","journal-title":"Osteoporos Int"},{"key":"pone.0227133.ref067","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1515\/CCLM.2007.306","article-title":"Circulating levels of osteoprotegerin and receptor actvator of NF-\u03baB ligand in patients with chronic renal failure","volume":"45","author":"M Shaarawy","year":"2007","journal-title":"Clin Chem Lab Med"},{"key":"pone.0227133.ref068","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.clinbiochem.2011.08.1143","article-title":"Mineral-bone metabolism markers in young hemodialysis patients","volume":"44","author":"A Osorio","year":"2011","journal-title":"Clin Biochem"},{"key":"pone.0227133.ref069","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00774-010-0192-1","article-title":"Changes in bone mineral parameters, vitamin D metabolites, and PTH measurements with varying chronic kidney disease stages","volume":"29","author":"S Patel","year":"2011","journal-title":"J Bone Miner Metab"},{"key":"pone.0227133.ref070","doi-asserted-by":"crossref","first-page":"460","DOI":"10.4103\/2230-8210.183457","article-title":"Prevalence and severity of disordered mineral metabolism in patients with chronic kidney disease: a study from a tertiary care hospital in India","volume":"20","author":"S Vikrant","year":"2016","journal-title":"Indian J Endocrinol Metab"},{"key":"pone.0227133.ref071","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ndt\/17.2.233","article-title":"Serum osteoprotegerin and renal osteodystrophy","volume":"17","author":"G Coen","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"pone.0227133.ref072","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12882-018-0960-z","article-title":"Association between low bone mass and the serum RANKL and OPG in patients with nephrolithiasis","volume":"19","author":"A Mansour","year":"2018","journal-title":"BMC Nephrology"},{"key":"pone.0227133.ref073","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.coph.2015.03.005","article-title":"Parathyroid hormone: anabolic and catabolic actions on the skeleton","volume":"22","author":"BC Silva","year":"2015","journal-title":"Curr Opin Pharmacol"},{"key":"pone.0227133.ref074","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1007\/s00198-005-1844-1","article-title":"The contribution of serum osteoprotegerin to bone mass and vertebral fractures in postmenopausal women","volume":"16","author":"P Mezquita-Raya","year":"2005","journal-title":"Osteopros Int"},{"key":"pone.0227133.ref075","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1359\/jbmr.2000.15.8.1526","article-title":"Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study","volume":"15","author":"P Garnero","year":"2000","journal-title":"J Bone Miner Res"},{"key":"pone.0227133.ref076","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0168-8278(02)00435-X","article-title":"High serum osteoprotegerin and low RANKL in primary biliary cirrhosis","volume":"38","author":"F Szalay","year":"2003","journal-title":"J Hepatol"},{"key":"pone.0227133.ref077","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/gme.0b013e318133a153","article-title":"Changes in serum levels of osteoprotegerin and soluble receptor activator for nuclear factor kappaB ligand after estrogen-progestogen therapy and their relationships with changes in bone mass in postmenopausal women","volume":"15","author":"JG Kim","year":"2008","journal-title":"Menopause"},{"key":"pone.0227133.ref078","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1359\/jbmr.090526","article-title":"Biochemical markers of bone turnover, hip bone loss, and fracture in older men: the MrOS study","volume":"24","author":"DC Bauer","year":"2009","journal-title":"J Bone Miner Res"},{"key":"pone.0227133.ref079","first-page":"1904","article-title":"The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation","volume":"82","author":"CJ Rosen","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"pone.0227133.ref080","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1359\/JBMR.050609","article-title":"Identification of osteopenic women at high risk of fracture: the OFELY study","volume":"20","author":"E Sornay-Rendu","year":"2005","journal-title":"J Bone Miner Res"},{"key":"pone.0227133.ref081","doi-asserted-by":"crossref","first-page":"608","DOI":"10.3109\/s10165-011-0455-2","article-title":"Biochemical markers of bone turnover as predictors of osteoporosis and osteoporotic fractures in men and women: 10-year follow-up of the Taiji cohort","volume":"21","author":"N Yoshimura","year":"2011","journal-title":"Mod Rheumatol"},{"key":"pone.0227133.ref082","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s00223-014-9842-y","article-title":"A meta-analysis of reference markers of bone turnover for prediction of fracture","volume":"94","author":"H Johansson","year":"2014","journal-title":"Calcif Tissue Int"},{"key":"pone.0227133.ref083","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1007\/s00198-011-1740-9","article-title":"Relationship between serum RANKL and RANKL in bone","volume":"22","author":"DM Findlay","year":"2011","journal-title":"Osteoporos Int"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0227133","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T13:28:19Z","timestamp":1577453299000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0227133"}},"subtitle":[],"editor":[{"given":"Xiaofang","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,12,27]]},"references-count":83,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,12,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0227133","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2019,12,27]]}}}